IL146798A0 - A structured peptide scaffold for displaying turn libraries on phage - Google Patents

A structured peptide scaffold for displaying turn libraries on phage

Info

Publication number
IL146798A0
IL146798A0 IL14679800A IL14679800A IL146798A0 IL 146798 A0 IL146798 A0 IL 146798A0 IL 14679800 A IL14679800 A IL 14679800A IL 14679800 A IL14679800 A IL 14679800A IL 146798 A0 IL146798 A0 IL 146798A0
Authority
IL
Israel
Prior art keywords
peptides
phage
directed
peptide scaffold
libraries
Prior art date
Application number
IL14679800A
Other languages
English (en)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL146798A0 publication Critical patent/IL146798A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14679800A 1999-06-14 2000-06-13 A structured peptide scaffold for displaying turn libraries on phage IL146798A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13901799P 1999-06-14 1999-06-14
PCT/US2000/016368 WO2000077194A1 (fr) 1999-06-14 2000-06-13 Structures peptidiques pour la mise en evidence de bibliotheques d'enroulements sur phage

Publications (1)

Publication Number Publication Date
IL146798A0 true IL146798A0 (en) 2002-07-25

Family

ID=22484754

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14679800A IL146798A0 (en) 1999-06-14 2000-06-13 A structured peptide scaffold for displaying turn libraries on phage

Country Status (10)

Country Link
US (2) US7235626B1 (fr)
EP (1) EP1187914B1 (fr)
JP (1) JP2003502304A (fr)
AT (1) ATE296350T1 (fr)
AU (1) AU782755C (fr)
CA (1) CA2376232A1 (fr)
DE (1) DE60020366T2 (fr)
ES (1) ES2242620T3 (fr)
IL (1) IL146798A0 (fr)
WO (1) WO2000077194A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE296350T1 (de) 1999-06-14 2005-06-15 Genentech Inc Strukturiertes peptidgerüst zur ausstellung von drehung-bibliotheken auf phage
DE10023743A1 (de) * 2000-05-15 2001-11-29 Max Planck Gesellschaft Peptidsubstrate zur direkten Messung enzymatischer Aktivitäten
US6914123B2 (en) * 2001-04-17 2005-07-05 Genentech, Inc. Hairpin peptides with a novel structural motif and methods relating thereto
WO2003102157A2 (fr) 2002-06-03 2003-12-11 Genentech, Inc. Bibliotheques de phages et anticorps synthetiques
WO2004020981A2 (fr) * 2002-08-30 2004-03-11 Rigel Pharmaceuticals, Inc. Procede de recherche systematique portant sur des peptides cycliques et d'identification de cibles a cet effet
AU2004205631A1 (en) * 2003-01-16 2004-08-05 Genentech, Inc. Synthetic antibody phage libraries
JP5553954B2 (ja) * 2003-11-15 2014-07-23 ポリファー リミテッド テンプレート固定β−ヘアピンループ模倣体とそのファージディスプレイにおける使用
US7785903B2 (en) 2004-04-09 2010-08-31 Genentech, Inc. Variable domain library and uses
US20090099031A1 (en) * 2005-09-27 2009-04-16 Stemmer Willem P Genetic package and uses thereof
MX2010001684A (es) * 2007-08-15 2010-04-21 Amunix Inc Composiciones y metodos para modificar propiedades de polipeptidos biologicamente activos.
CN102348715B (zh) 2009-02-03 2017-12-08 阿穆尼克斯运营公司 延伸重组多肽和包含该延伸重组多肽的组合物
JPWO2011024887A1 (ja) * 2009-08-26 2013-01-31 国立大学法人 岡山大学 環状ペプチドを含む結合体およびその作製方法
WO2011071280A2 (fr) * 2009-12-11 2011-06-16 광주과학기술원 Liant peptidique bipode à ciblage intracellulaire
KR101341640B1 (ko) * 2010-02-05 2013-12-16 한국전자통신연구원 단백질 미세 구조 분석 방법 및 단백질 미세 구조 분석용 어레이
JP4955795B2 (ja) * 2010-05-14 2012-06-20 株式会社日本製鋼所 造粒方法及び造粒装置
JP6092104B2 (ja) 2010-08-13 2017-03-08 ミティ・バイオシステムズ・ゲーエムベーハー 修飾ペプチドディスプレイ
EP4122945A1 (fr) 2013-12-23 2023-01-25 University of Rochester Procédés et compositions pour la synthèse ribosomique de peptides macrocycliques
EP2940138B1 (fr) * 2014-04-30 2018-02-28 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Bibliothèque à affichage de phages
US10822604B2 (en) 2014-05-02 2020-11-03 Morphosys Ag Peptide libraries
EP3180431A1 (fr) * 2014-08-11 2017-06-21 Miti Biosystems GmbH Peptides cycliques exprimés par un matériel génétique
AU2015371172B2 (en) 2014-12-22 2021-05-13 Lanthiopep B.V. Novel methods for displaying cyclic peptides on bacteriophage particles
WO2021007436A1 (fr) * 2019-07-09 2021-01-14 Tavotek Biotherapeutics (Hong Kong) Limited Peptides tricycliques en tant que liants et modulateurs protéiques et utilisations de ceux-ci
WO2021221783A1 (fr) 2020-05-01 2021-11-04 Massachusetts Institute Of Technology Procédés d'identification de ligands de ciblage de récepteur antigénique chimérique et leurs utilisations
US20210338833A1 (en) 2020-05-01 2021-11-04 Massachusetts Institute Of Technology Chimeric antigen receptor-targeting ligands and uses thereof
TWI845133B (zh) * 2022-01-27 2024-06-11 中央研究院 胜肽介導的活性劑遞送

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ215865A (en) 1985-04-22 1988-10-28 Commw Serum Lab Commission Method of determining the active site of a receptor-binding analogue
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5750373A (en) 1990-12-03 1998-05-12 Genentech, Inc. Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants
US5650489A (en) 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
US5885780A (en) 1991-07-19 1999-03-23 University Of Utah Method of obtaining small conformationally rigid conopeptides
WO1994003494A1 (fr) 1992-08-06 1994-02-17 The Board Of Trustees Of The University Of Illinois Agents mimetiques restreints dans leur conformation de girations inverses, et peptides les contenant
EP0788370A4 (fr) 1993-07-09 1998-07-08 Smithkline Beecham Corp Bibliotheques semi-aleatoires de peptides cycliques
US5830851A (en) 1993-11-19 1998-11-03 Affymax Technologies N.V. Methods of administering peptides that bind to the erythropoietin receptor
US5534615A (en) 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
US5824483A (en) 1994-05-18 1998-10-20 Pence Inc. Conformationally-restricted combinatiorial library composition and method
WO1995034683A1 (fr) 1994-06-10 1995-12-21 Symbiotech, Inc. Procede de detection de composes utilisant un bacteriophage lambdoique modifie genetiquement
US6100377A (en) 1994-06-10 2000-08-08 The Trustees Of The University Of Pennsylvania Constrained peptides
US5627024A (en) 1994-08-05 1997-05-06 The Scripps Research Institute Lambdoid bacteriophage vectors for expression and display of foreign proteins
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US6475806B1 (en) 1995-06-07 2002-11-05 Praecis Pharmaceuticals, Inc. Anchor libraries and identification of peptide binding sequences
US6013458A (en) 1995-10-27 2000-01-11 Molecumetics, Ltd. Reverse-turn mimetics and methods relating thereto
SE506771C2 (sv) 1996-02-06 1998-02-09 Gotpat 105 Ab Fusionsprotein, bakteriofag uttryckande proteinet, dessas användning samt hybridoma celler och monoklonaler producerade av cellerna
US5866341A (en) 1996-04-03 1999-02-02 Chugai Pharmaceutical Co., Ltd. Compositions and methods for screening drug libraries
US5766905A (en) 1996-06-14 1998-06-16 Associated Universities Inc. Cytoplasmic bacteriophage display system
CA2324284A1 (fr) 1998-04-02 1999-10-14 Rigel Pharmaceuticals, Inc. Peptides provoquant la formation de structures compactes
US6180343B1 (en) 1998-10-08 2001-01-30 Rigel Pharmaceuticals, Inc. Green fluorescent protein fusions with random peptides
ATE296350T1 (de) 1999-06-14 2005-06-15 Genentech Inc Strukturiertes peptidgerüst zur ausstellung von drehung-bibliotheken auf phage
CN1318084C (zh) 2000-05-26 2007-05-30 奥索-麦克尼尔药品公司 神经保护肽

Also Published As

Publication number Publication date
US7235626B1 (en) 2007-06-26
CA2376232A1 (fr) 2000-12-21
WO2000077194A1 (fr) 2000-12-21
ES2242620T3 (es) 2005-11-16
AU782755B2 (en) 2005-08-25
EP1187914B1 (fr) 2005-05-25
AU5611900A (en) 2001-01-02
DE60020366D1 (de) 2005-06-30
US20060110777A1 (en) 2006-05-25
JP2003502304A (ja) 2003-01-21
ATE296350T1 (de) 2005-06-15
DE60020366T2 (de) 2006-02-02
AU782755C (en) 2006-04-27
EP1187914A1 (fr) 2002-03-20

Similar Documents

Publication Publication Date Title
IL146798A0 (en) A structured peptide scaffold for displaying turn libraries on phage
Melendez et al. Aza-amino acid scan for rapid identification of secondary structure based on the application of N-Boc-Aza1-dipeptides in peptide synthesis
Jwad et al. Strategies for fine-tuning the conformations of cyclic peptides
Choi et al. Recent trends in cyclic peptides as therapeutic agents and biochemical tools
Freidinger Design and synthesis of novel bioactive peptides and peptidomimetics
Joo et al. High-throughput sequence determination of cyclic peptide library members by partial Edman degradation/mass spectrometry
Souers et al. β-Turn mimetic library synthesis: scaffolds and applications
Brouwer et al. Peptido sulfonyl fluorides as new powerful proteasome inhibitors
WO2004035735A3 (fr) Echafaudage peptidique structure destine a representer des bibliotheques d'inversion sur des bacteriophages
Spatola et al. Rediscovering an endothelin antagonist (BQ-123): A self-deconvoluting cyclic pentapeptide library
Kelly et al. Geometrically diverse lariat peptide scaffolds reveal an untapped chemical space of high membrane permeability
CA2466591C (fr) Peptidomimetiques fixes sur matrice, utilises comme inhibiteurs des proteases a serine
Witte et al. Solution-and solid-phase synthesis of N-protected glycopeptide esters of the benzyl type as substrates for subtilisin-catalyzed glycopeptide couplings
Slomczynska et al. Electrochemical cyclization of dipeptides to form novel bicyclic, reverse-turn peptidomimetics. 2. Synthesis and conformational analysis of 6, 5-bicyclic systems
Lee et al. Oligomers of N-substituted β2-homoalanines: Peptoids with backbone chirality
Turner et al. Selective, on-resin N-methylation of peptide N-trifluoroacetamides
Park et al. Facile solid-phase parallel synthesis of linear and cyclic peptoids for comparative studies of biological activity
Chingle et al. Solid-Phase Azopeptide Diels–Alder Chemistry for Aza-pipecolyl Residue Synthesis To Study Peptide Conformation
Lucke et al. Designing supramolecular structures from models of cyclic peptide scaffolds with heterocyclic constraints
Marciano et al. N-acetylation of biodegradable supramolecular peptide nanofilaments selectively enhances their proteolytic stability for targeted delivery of gold-based anticancer agents
De Marco et al. In-Peptide synthesis of imidazolidin-2-one scaffolds, equippable with proteinogenic or taggable/linkable side chains, general promoters of unusual secondary structures
Felder et al. Combinatorial compound libraries for enhanced drug discovery approaches
Yuan et al. Synthesis and pharmacological evaluation of an analogue of the peptide hormone oxytocin that contains a mimetic of an inverse γ-turn
Wittelsberger et al. Introduction of a cis-prolyl mimic in position 7 of the peptide hormone oxytocin does not result in antagonistic activity
Wierzbicka et al. One-Pot Cyclization and Cleavage of Peptides with N-Terminal Cysteine via the N, S-Acyl Shift of the N-2-[Thioethyl] glycine Residue